Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DOCETAXEL Cause Intentional product use issue? 129 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 129 reports of Intentional product use issue have been filed in association with DOCETAXEL (Docetaxel). This represents 0.2% of all adverse event reports for DOCETAXEL.

129
Reports of Intentional product use issue with DOCETAXEL
0.2%
of all DOCETAXEL reports
18
Deaths
66
Hospitalizations

How Dangerous Is Intentional product use issue From DOCETAXEL?

Of the 129 reports, 18 (14.0%) resulted in death, 66 (51.2%) required hospitalization, and 1 (0.8%) were considered life-threatening.

Is Intentional product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DOCETAXEL. However, 129 reports have been filed with the FAERS database.

What Other Side Effects Does DOCETAXEL Cause?

Alopecia (29,347) Emotional distress (8,373) Anxiety (7,379) Psychological trauma (6,981) Madarosis (6,883) Hair texture abnormal (6,204) Hair colour changes (6,078) Hair disorder (5,652) Pain (5,414) Diarrhoea (4,115)

What Other Drugs Cause Intentional product use issue?

INFLIXIMAB (11,028) RITUXIMAB (9,602) INFLIXIMAB-DYYB (7,549) TOCILIZUMAB (5,078) METHOTREXATE (4,087) PREDNISONE (3,961) ABATACEPT (3,693) ADALIMUMAB (3,557) NIVOLUMAB (3,297) LEFLUNOMIDE (3,280)

Which DOCETAXEL Alternatives Have Lower Intentional product use issue Risk?

DOCETAXEL vs DOCETAXEL ANHYDROUS DOCETAXEL vs DOCETAXEL\DOCETAXEL ANHYDROUS DOCETAXEL vs DOCONEXENT DOCETAXEL vs DOCONEXENT\ICOSAPENT DOCETAXEL vs DOCONEXENT\ICOSAPENT\PHOSPHATIDYL SERINE

Related Pages

DOCETAXEL Full Profile All Intentional product use issue Reports All Drugs Causing Intentional product use issue DOCETAXEL Demographics